There are 2789 resources available
1438TiP - INTEGRATE IIb: A randomised phase III open label study of regorafenib + nivolumab vs standard chemotherapy in refractory advanced gastro-oesophageal cancer (AGOC)
Presenter: Nick Pavlakis
Session: ePoster Display
1352P - A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy
Presenter: Giulia Mazzaschi
Session: ePoster Display
1353P - Similarities and differences in the spatial distribution of brain metastases in small cell lung cancer and non-small cell lung cancer: Quantitative analysis and identifying metastatic risk region may be helpful for the whole-brain radiotherapy with non-uniform dose prescriptions
Presenter: Rongjie Tao
Session: ePoster Display
Resources:
Abstract
1518P - Treating cancer with unknown primary (CUP) in Germany – an economic perspective
Presenter: Bernhard Mörtl
Session: ePoster Display
1446P - Weekly hypofractionated palliative radiotherapy in poor performance status and elderly patients unfit for standard radiotherapy: Survival, acute and late toxicity outcomes
Presenter: Carlo Soatti
Session: ePoster Display
1447P - Efficacy and toxicity profile of trans dermal buprenorphine for cancer pain management: Experience from a tertiary care center in northern India
Presenter: Varun Goel
Session: ePoster Display
1357P - A deep radiomics approach to assess PD-L1 expression and clinical outcomes in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: A multicentric study
Presenter: Marion Tonneau
Session: ePoster Display
1358P - Phase I dose-escalation study to evaluate safety and clinical activity of c-MET inhibitor ABN401 in patients with advanced solid tumor
Presenter: Dae Ho Lee
Session: ePoster Display
1451P - An onco-palliative expertise unit in a French comprehensive cancer center: Experience at 2 years
Presenter: Perrine RENARD
Session: ePoster Display